Brief: Briacell Therapeutics Files For Offering Of Up To 2.3 Mln Common Units, Up To 2.3 Mln Pre-Funded Units
22/04/2025 21:50
April 22 (Reuters) - Briacell Therapeutics Corp BCT.TO: BRIACELL THERAPEUTICS FILES FOR OFFERING OF UP TO 2.3 MILLION COMMON UNITS, UP TO 2.3 MILLION PRE-FUNDED UNITS Source text: [ID:n0001641172-25-005677] Further company coverage: BCT.TO ((Reuters.Briefs@thomsonreuters.com))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study